TEIJINHuman Chemistry, Human Solutions

Teijin Pharma Limited GLOBAL

  • Site Map
  • Contact Us
  • Enlarge Text

menu

  • About Us
  • Our Business Structure
  • Site Map
  • Contact Us

About Us：TOP

  • Corporate Philosophy
  • Message from the President
  • Group Synergies
  • Office Locations
  • Alliance Partners
  • History
  • Corporate Social Responsibility
  • Project Stories
  • News

Our Business Structure：TOP

Business Fields
  • About Teijin Pharma
Business Activities
  • Research & Development
  • Industrial Technology
  • Regulatory Compliance

  • Japan Local Site日本

Home > News Release > 2020

News Release

2020

Dec. 18, 2020
  • Teijin Pharma and TransThera Biosciences Form Strategic R&D Collaboration
Dec. 04, 2020
  • Teijin Starts Exclusive Sales of Merz’s Xeomin® Botulinum Toxin Type A in Japan
Jun. 29, 2020
  • Teijin Receives Marketing Approval for Merz’s Xeomin® Botulinum Toxin Type A in Japan

Page Top

News Release

  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • Notice

We use cookies to help improve your experience on our website. Clink on "Agree" to agree and proceed, or click on "See Details" for more information and settings of cookies.

See Details
  • Terms & Conditions of Use
  • Privacy Policy

Copyright © Teijin Pharma Limited. All Rights Reserved.